Nivolumab (anti-PD-1) | 946414-94-4 | BMS-936558 | ONO-4538

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$530.00	Visible after login	- +
5 mg	3-5days	$1200.00	Visible after login	- +
10 mg	3-5days	$1800.00	Visible after login	- +
50 mg	3-5days	$4000.00	Visible after login	- +
100 mg	3-5days	$6600.00	Visible after login	- +

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

1 mg

3-5days

$530.00

Visible after login

- +

5 mg

3-5days

$1200.00

Visible after login

- +

10 mg

3-5days

$1800.00

Visible after login

- +

50 mg

3-5days

$4000.00

Visible after login

- +

100 mg

3-5days

$6600.00

Visible after login

- +

Product Overview

Product Name	Nivolumab (anti-PD-1) (Synonyms:BMS-936558; ONO-4538; MDX-1106)
CAS	946414-94-4
MW	143599.09
Appearance	Colorless to light yellow liquid
Storage condition	Sealed and stored at ≤-80℃, away from light. Avoid freeze-thaw cycles

Product details

1.Nivolumab (anti-PD-1) is a genetically engineered, fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1,PCD-1) with immune checkpoint inhibitory and antineoplastic activities. MW : 143.597 KD.

2.Nivolumab is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CLA1002

Nivolumab (anti-PD-1) (Synonyms:BMS-936558; ONO-4538; MDX-1106)

946414-94-4 95+%